Home-Based Transcranial Direct Current Stimulation in Painful Diabetic Peripheral Neuropathy: A Double Blinded, Randomized, Low-Intensity Sham-Controlled Crossover Trial
Rattachement africain : dk. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
OBJECTIVES: To evaluate the analgesic effect of four weeks home-based transcranial direct current stimulation (tDCS) compared with low-intensity sham stimulation in individuals with type 1 diabetes mellitus and painful diabetic peripheral neuropathy. MATERIALS AND METHODS: A total of 35 participants with type 1 diabetes mellitus and painful diabetic peripheral neuropathy were enrolled in a home-based, randomized, double-blind, sham-controlled, crossover study. Each participant underwent four weeks of active (2 mA) and sham (0.3 mA) tDCS in a randomized order. Clinical and experimental end points were assessed before and after each treatment. The primary end point was pain relief, measured daily using a numeric rating scale. Secondary end points included various questionnaires. Quantitative sensory testing was used to assess the pain system. RESULTS: No significant differences in pain scores were observed after four weeks of active tDCS compared with sham (mean difference in average pain 0.03 (95% CI, -0.40 to 0.46; p = 0.89, mean difference in maximal pain 0.09 (95% CI, -0.42 to 0.60; p = 0.73). However, active tDCS reduced pain compared with baseline: Average pain (p = 0.026) and maximum pain (p = 0.012), unlike sham tDCS. However, taking all four weeks of treatment into consideration, sham tDCS reduced pain scores (p < 0.05). No differences were found between the treatments for the secondary outcomes. Responders to active tDCS showed increased temporal summation and lower pressure pain thresholds. CONCLUSIONS: Active tDCS significantly reduced pain compared with baseline but did not show an improvement over low-intensity sham tDCS. Responders to active tDCS exhibited features of central sensitization. Stimulation intensity may influence tDCS effectiveness. CLINICAL TRIAL REGISTRATION: The clinicaltrial.gov registration number for the study is NCT06152887.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Home-Based Transcranial Direct Current Stimulation in Painful Diabetic Peripheral Neuropathy: A Double Blinded, Randomized, Low-Intensity Sham-Controlled Crossover Trial
- Date Crossref
- 01/07/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.